These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9824684)

  • 1. The MEK inhibitor PD 098059 inhibits prolactin-induced Nb2 cell mitogenesis but not milk product synthesis in cultured mouse mammary tissues.
    Yu TX; Rillema JA
    Biochim Biophys Acta; 1998 Nov; 1448(1):126-34. PubMed ID: 9824684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin inhibits prolactin-induced Nb2 cell mitogenesis and milk product synthesis in mouse mammary gland explants.
    Camarillo IG; Rillema JA
    Proc Soc Exp Biol Med; 1997 Oct; 216(1):98-103. PubMed ID: 9316617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP; Buckley DJ; Buckley AR
    Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prolactin on casein kinase II, MAP kinase and PKC in rabbit mammary cells and Nb2 rat lymphoid cells.
    Mitev V; Bayat-Sarmadi M; Lemnaouar M; Puissant C; Houdebine LM
    Biochem Pharmacol; 1996 Dec; 52(11):1719-27. PubMed ID: 8986134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of receptor-associated kinase, tyrosine kinase, and MAP kinase is required for prolactin-mediated macromolecular biosynthesis and mitogenesis in Nb2 lymphoma.
    Carey GB; Liberti JP
    Arch Biochem Biophys; 1995 Jan; 316(1):179-89. PubMed ID: 7840614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells.
    Das R; Vonderhaar BK
    Breast Cancer Res Treat; 1996; 40(2):141-9. PubMed ID: 8879680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants.
    Campbell GS; Argetsinger LS; Ihle JN; Kelly PA; Rillema JA; Carter-Su C
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5232-6. PubMed ID: 7515493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of P13K in prolactin-stimulated milk product formation and iodide transport in mouse mammary explants.
    Hang J; Rillema JA
    Proc Soc Exp Biol Med; 1998 Nov; 219(2):154-9. PubMed ID: 9790174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
    Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
    Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin and epidermal growth factor stimulate adipophilin synthesis in HC11 mouse mammary epithelial cells via the PI3-kinase/Akt/mTOR pathway.
    Pauloin A; Chanat E
    Biochim Biophys Acta; 2012 May; 1823(5):987-96. PubMed ID: 22426621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rapamycin on prolactin-stimulated S6 kinase activity and milk product formation in mouse mammary explants.
    Hang J; Rillema JA
    Biochim Biophys Acta; 1997 Sep; 1358(2):209-14. PubMed ID: 9332457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen inhibits prolactin signal transduction in ER - NOG-8 mammary epithelial cells.
    Das R; Vonderhaar BK
    Cancer Lett; 1997 Jun; 116(1):41-6. PubMed ID: 9177456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes.
    Karpova AY; Abe MK; Li J; Liu PT; Rhee JM; Kuo WL; Hershenson MB
    Am J Physiol; 1997 Mar; 272(3 Pt 1):L558-65. PubMed ID: 9124614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
    Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
    Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role for protein kinase B in the anti-apoptotic effect of prolactin in rat Nb2 lymphoma cells.
    Al-Sakkaf KA; Mooney LM; Dobson PR; Brown BL
    J Endocrinol; 2000 Oct; 167(1):85-92. PubMed ID: 11018756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a tyrosine kinase inhibitor, genistein, on the actions of prolactin in cultured mouse mammary tissues.
    Fan G; Rillema JA
    Mol Cell Endocrinol; 1992 Jan; 83(1):51-5. PubMed ID: 1312959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential tyrosyl-phosphorylation of multiple mitogen-activated protein kinase isoforms in response to prolactin in Nb2 lymphoma cells.
    Camarillo IG; Linebaugh BE; Rillema JA
    Proc Soc Exp Biol Med; 1997 Jun; 215(2):198-202. PubMed ID: 9160049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK inhibition augments Raf activity, but has variable effects on mitogenesis, in vascular smooth muscle cells.
    Weiss RH; Maga EA; Ramirez A
    Am J Physiol; 1998 Jun; 274(6):C1521-9. PubMed ID: 9696694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
    Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
    Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.